Florida hospitals asked to detail executive pay info to lawmakers

The Florida House of Representatives is asking the state’s hospitals for “extensive financial data,” according to the Tampa Bay Times, as the chamber considers a state budget with nearly $600 million in cuts affecting those facilities.

The Times reported all members of the Florida Hospital Association (FHA) have been sent a request for data on all executive compensation over $200,000, along with their associated job title. They’ve also been asked to detail privately-raised funds, money spent on lobbyists and FHA dues, as well as their hospital or health system’s current market capitalization.  

The information made used to justify legislators’ cuts to hospital Medicaid payments, though how big the reduction will be is still up for debate.

Florida Gov. Rick Scott—himself a former hospital executive at the Hospital Corporation of America—had initially proposed a $929 million cut in hospital funding. The Florida House proposed a lower cut of $621 million, according to the Naples Daily News, while the Florida Senate is only calling for a $259 million cut, according to Florida Health News.

FHA President Bruce Reuben has said the state should be prioritizing Medicaid funding, not cutting it to make up for tax cuts elsewhere in the state’s $81 billion budget.

“We’re going to do our best to educate people that cutting this much money for funding health care services to low-income children, pregnant women, the disabled and the elderly is hard to understand, especially when we don’t have a deficit,” he said to the Naples Daily News.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.